Neo-Bionica

About

Neo-Bionica provides end-to-end prototyping, clinical-trial support and low-volume manufacturing for implantable and wearable medtech, specializing in bioelectronics and neurotechnology, operating workshops and cleanrooms for microfabrication, assembly, and testing.

Mission

Founded in 2021 as a joint initiative of the Bionics Institute and the University of Melbourne and based at St Vincent’s Hospital Melbourne, Neo-Bionica was developed to fill a gap in medical device prototype manufacturing capability. The company offers end-to-end medical device prototype development, clinical trials, and initial low-volume manufacturing support, specialising in engineering, bioelectronics and neurotechnology. It focuses on designing and developing implantable and wearable medical devices and provides advanced commercialisation and manufacturing services to medtech innovators. Neo-Bionica currently operates two workshops and two independent cleanrooms for microfabrication, assembly and testing. The $5 million investment from Breakthrough Victoria will be used to expand manufacturing capability, facilities and market presence and is predicted to generate up to 45 new jobs. CEO Ludovic Labat said the funding will accelerate the company’s domestic and global expansion plans.

Quick Facts